Concepedia

Publication | Closed Access

Metformin synergistically enhances the antitumour activity of Lenvatinib in hepatocellular carcinoma by altering <scp>AKT‐FOXO3</scp> signalling pathway

DOI

12

Citations

43

References

2023

Year

Yizhe Cheng, Ping Zhan, Jing Lü, Yuyan Lu, Changhong Luo, Xuesong Cen, Fuqiang Wang, Chengrong Xie, Zhenyu Yin
Liver International

Abstract

The Lenvatinib-Metformin combination may provide a potential therapeutic strategy to improve the prognosis of HCC patients.

References

YearCitations

Page 1